Scilex Holding Company Employee Benefits and Share-based Compensation
Scilex Holding Company (SCLX) reported Employee Benefits and Share-based Compensation of $3.63 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-20.
Financial Statements › Notes › Compensation Related Costs
us-gaap:EmployeeBenefitsAndShareBasedCompensation · last filed 2026-05-20
- Scilex Holding Company employee benefits and share-based compensation for the quarter ending 2026-03-31 was $3.63M, a 9.51% increase year-over-year.
- Scilex Holding Company employee benefits and share-based compensation for the quarter ending 2025-03-31 was $3.31M.
- Scilex Holding Company employee benefits and share-based compensation for fiscal 2025 was $15.49M, a 1.26% decline from fiscal 2024.
- Scilex Holding Company employee benefits and share-based compensation for fiscal 2024 was $15.69M.
| Period end | Employee Benefits and Share-based Compensation 3 month | Employee Benefits and Share-based Compensation 12 month |
|---|---|---|
| 2026-03-31 | $3.63M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $15.49M 10-K · filed 2026-04-10 | |
| 2025-03-31 | $3.31M 10-Q · filed 2026-05-20 | |
| 2024-12-31 | $15.69M 10-K · filed 2026-04-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |